FAM115A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.343200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.649000E-01
Normal-vs-Stage2
6.684200E-01
Normal-vs-Stage3
4.038000E-01
Normal-vs-Stage4
3.119800E-01
Stage1-vs-Stage2
3.958600E-01
Stage1-vs-Stage3
7.496500E-02
Stage1-vs-Stage4
5.655400E-01
Stage2-vs-Stage3
1.950980E-01
Stage2-vs-Stage4
1.232440E-01
Stage3-vs-Stage4
9.901700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.548600E-01
Normal-vs-AfricanAmerican
4.747800E-01
Normal-vs-Asian
9.975600E-01
Caucasian-vs-AfricanAmerican
5.671000E-01
Caucasian-vs-Asian
4.024600E-01
AfricanAmerican-vs-Asian
2.727200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.873400E-01
Normal-vs-Female
5.872000E-01
Male-vs-Female
5.484400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.274600E-01
Normal-vs-Age(41-60Yrs)
4.270200E-01
Normal-vs-Age(61-80Yrs)
7.484000E-01
Normal-vs-Age(81-100Yrs)
9.867000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.297200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.406200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.929400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.389500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.262370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.148400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.435200E-01
Normal-vs-Daily Drinker
9.713000E-01
Normal-vs-Weekly Drinker
7.051200E-01
Normal-vs-Occasional Drinker
4.768000E-01
Normal-vs-Social Drinker
4.489600E-01
Non Drinker-vs-Daily Drinker
8.214000E-01
Non Drinker-vs-Weekly Drinker
4.700400E-01
Non Drinker-vs-Occasional Drinker
1.255240E-01
Non Drinker-vs-Social Drinker
1.226960E-01
Daily Drinker-vs-Weekly Drinker
4.384000E-01
Daily Drinker-vs-Occasional Drinker
1.015760E-01
Daily Drinker-vs-Social Drinker
1.103780E-01
Weekly Drinker-vs-Occasional Drinker
4.192400E-01
Weekly Drinker-vs-Social Drinker
3.224800E-01
Occasional Drinker-vs-Social Drinker
7.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.643210E-01
Normal-vs-Grade 2
7.361800E-02
Normal-vs-Grade 3
5.555900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.227600E-01
Grade 1-vs-Grade 3
6.425400E-01
Grade 1-vs-Grade 4
1.643210E-01
Grade 2-vs-Grade 3
1.511590E-01
Grade 2-vs-Grade 4
7.361800E-02
Grade 3-vs-Grade 4
5.555900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.335400E-01
Normal-vs-NonDiabetic
7.032000E-01
Diabetic-vs-NonDiabetic
5.504400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.030400E-01
Normal-vs-NoPancreatitis
6.875200E-01
Pancreatitis-vs-NoPancreatitis
4.480400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.229000E-01
Normal-vs-N1
6.497000E-01
N0-vs-N1
5.968400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.388600E-01
Normal-vs-TP53-NonMutant
4.865000E-01
TP53-Mutant-vs-TP53-NonMutant
6.836600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
